All Articles

Global burden of liver cancer mortality due to alcohol use from 1990 to 2021 and predictions to 2050

Gut microbiota as predictors of immunotherapy response in hepatocellular carcinoma

Hepatocellular carcinoma tumor immune microenvironment: heterogeneity and therapeutic strategies

A review on decellularization scaffolding for liver regeneration in transplantation

A systematic review of comparative economic analyses of systemic therapies for hepatocellular carcinoma

Regional dietary patterns and risk of primary liver cancer in anhui, china: a population-based case-control study

Targeting gut microbiota to overcome immunotherapy resistance in hepatocellular carcinoma: from mechanisms to clinical practice

Helicobacter pylori is associated with a higher risk of MAFLD prevalence and all-cause mortality: results from the NHANES III follow-up study

An activated CD8⁺ T cell-based signature stratifies prognosis and suggests differential sensitivity to immune checkpoint inhibitors in hepatocellular carcinoma

Incretin-based therapies: a new era in metabolic liver disease management

Impact of metabolic reprogramming on the immune response in hepatocellular carcinoma

Yttrium-90 combination therapies in hepatocellular carcinoma: current evidence and future directions

Patient-derived tumor organoid models for functional precision oncology in hepatocellular carcinoma

Conversion and neoadjuvant systemic therapy for intrahepatic cholangiocarcinoma: from technical resectability to biology-driven surgical selection - a systematic review and meta-analysis

Resistance to immune checkpoint inhibitors in hepatocellular carcinoma: mechanisms and combination strategies to overcome it

Histone lactylation in hepatocellular carcinoma: a key epigenetic hub linking metabolic reprogramming and the immune microenvironment

Multi-task neural network enhanced by data augmentation and ROI optimization for prognosis and MVI prediction in HCC using contrast-enhanced CT

Review of advances in FOLFOX-HAIC for conversion, neoadjuvant, and adjuvant therapy in hepatocellular carcinoma